U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 11 results

Status:
US Approved Rx (2023)
First approved in 2009

Class (Stereo):
CHEMICAL (ACHIRAL)



Febuxostat (ULORIC) is a novel, xanthine oxidase/dehydrogenase (XO/XDH) inhibitor being developed by Teijin, TAP Pharmaceuticals, and Ipsen for the treatment of gout. The currently available XO inhibitor, allopurinol, has been associated with serious...
Status:
US Approved Rx (2000)
First approved in 2000

Class (Stereo):
CHEMICAL (RACEMIC)



Cevimeline is a cholinergic agonist, which binds to muscarinic receptors. Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands, such as salivary and sweat glands and increase tone of the smooth muscle in the gastrointest...
Status:
US Approved Rx (1985)
First approved in 1985

Class (Stereo):
CHEMICAL (ABSOLUTE)



Auranofin (brand name Ridaura) is an organogold compound classified by the World Health Organization as an antirheumatic agent. Ridaura is indicated in the management of adults with active classical or definite rheumatoid arthritis (ARA criteria) who...
Status:
US Approved Rx (2019)
First approved in 1966

Class (Stereo):
CHEMICAL (ACHIRAL)



Allopurinol is a xanthine oxidase inhibitor used to decrease high blood uric acid levels. Allopurinol is specifically used to prevent gout, prevent specific types of kidney stones, and for the high uric acid levels that can occur with chemotherapy. A...
Status:
US Approved Rx (2018)
First approved in 1955

Class (Stereo):
CHEMICAL (RACEMIC)



Hydroxychloroquine possesses antimalarial properties and also exerts a beneficial effect in lupus erythematosus (chronic discoid or systemic) and acute or chronic rheumatoid arthritis. Although the exact mechanism of action is unknown, it may be base...
Status:
US Approved Rx (2023)
First approved in 1951

Class (Stereo):
CHEMICAL (ACHIRAL)



Probenecid is the prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tub...
Status:
US Approved Rx (2019)
First marketed in 1921

Class (Stereo):
CHEMICAL (ABSOLUTE)

Targets:


Colchicine is an alkaloid obtained from the plant colchicum autumnale (also known as "meadow saffron"). Colchicine is an alternative medication for those unable to tolerate NSAIDs in gout. Mechanism of action of colchicine is inhibition of microtubul...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Benzbromarone (INN) is a uricosuric agent and non-competitive inhibitor of xanthine oxidase used in the treatment of gout, especially when the first line treatment, allopurinol, fails or produces intolerable adverse effects. It is structurally relate...
Status:
US Approved Rx (2010)
First approved in 2010

Class:
PROTEIN

Status:
US Approved Rx (2019)
First approved in 1998

Class (Stereo):
CHEMICAL (ACHIRAL)



Teriflunomide (trade name Aubagio, marketed by Sanofi) is the active metabolite of leflunomide and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis by blocking the enzyme dihydroorotate dehydrogenase. Teriflunomide was investig...

Showing 1 - 10 of 11 results